Lyell Immunopharma, Inc. Common Stock
€14.38
EUR
Last updated on --.
24h volume84.01K
24h highest14.7989 EUR
24h lowest13.7670 EUR
24h Price movement+2.20%
LYEL recent prices
24 Hours
+2.20%+€0.30956
30 days
-21.27%-€3.930
60 days
-12.29%-€2.038
90 days
-29.50%-€6.089
Key data
Previous close14.0766 EUR
Market cap345.52M EUR
Volume84.01K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-9.0805 EUR
Net income (FY)-211.88M EUR
Revenue (FY)26.66K EUR
Last report dateMay 6, 2026
About Lyell Immunopharma, Inc. Common Stock
HeadquartersSOUTH SAN FRANCISCO
Employees (FY)161.00
Revenue per employee (FY)165.57 EUR
Net income per employee (FY)-1.32M EUR
Listed onNasdaq
LYEL conversion tables
 |  |
|---|---|
| 0.5 LYEL | 7.193 EUR |
| 1 LYEL | 14.38 EUR |
| 5 LYEL | 71.93 EUR |
| 10 LYEL | 143.86 EUR |
| |
|---|---|
| 0.5 EUR | 0.034756 LYEL |
| 1 EUR | 0.069511 LYEL |
| 5 EUR | 0.34756 LYEL |
| 10 EUR | 0.69511 LYEL |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
LYEL is trading at €14.38, +2.20% over the last 24 hours. Track live moves on the price chart at the top of this page.
The LYEL stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. LYEL is currently trading at €14.38, +2.20% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on LYEL price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. LYEL's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from LYEL; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against LYEL's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Lyell Immunopharma, Inc. Common Stock's market cap is currently 345.52M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume84.01K
24h highest14.7989 EUR
24h lowest13.7670 EUR
24h Price movement+2.20%
Start trade with LYEL Perpetual
Sign up to trade